Despite her active and healthy lifestyle, Sasha Barden felt stuck in her weight loss journey. She decided to try GLP-1 medications to support her weight loss goal. After six months on Wegovy ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

Researchers are working to make GLP-1 medications like Ozempic and Wegovy available to consumers as pills, instead of being produced as solely inject-able treatments.

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

Researchers said a single daytime sample of serum 17-hydroxyprogesterone and/or androstenedione is sufficient to monitor ...

A specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and weight – without ...

Starting Jan. 1, Point32Health, the owner of Harvard Pilgrim Health Care and Tufts Health Plan, will dramatically change how and when it pays for Zepbound— the insurer’ s preferred GLP-1 ...

(HealthDay News) — Glucagon-like peptide ... GLP-1 RAs in a real-world setting. Data were included for 262 adults with a body mass index ≥27 kg/m 2 who were initiated on liraglutide or ...

Glucagon-like peptide-1 receptor ... were treated for obesity with GLP-1 RAs in a real-world setting. Data were included for 262 adults with a body mass index ≥27 kg/m 2 who were initiated on ...

kDepartment of Cell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands lDepartment of Biomedical Data Sciences, Section Molecular Epidemiology, Leiden University Medical ...

People taking semaglutide or liraglutide reduced their ... These glucagon-like peptide-1 (GLP-1) drugs mimic the GLP-1 hormone, which helps control insulin and blood sugar levels, decreases ...